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Voiding Dysfunction
Correlation of Male Overactive Bladder with Intravesical Prostatic 
Protrusion
Ki Hong Kim, Young Sig Kim
Department of Urology, National Health Insurance Corporation Ilsan Hospital, Goyang, Korea
Purpose: Male overactive bladder (OAB) may be caused by prostatic pathologies such 
as bladder outlet obstruction (BOO). Intravesical prostatic protrusion (IPP) has been 
found to correlate with BOO and acute urinary retention. We investigated the inter-
relation between male OAB symptoms and IPP for estimating anatomical changes to 
the prostate.
Materials and Methods: We assessed 179 consecutive men aged ＞40 years who pre-
sented with lower urinary tract symptoms. The initial evaluation included Interna-
tional Prostate Symptom Score (IPSS) and quality of life assessments, transrectal ultra-
sonography (TRUS), uroflowmetry, and postvoid residual urine volume. The degree of 
IPP was determined by the distance from the tip of the protrusion to the circumference 
of the bladder at the base of the prostate gland. Patients with IPP ＜0.5 cm were defined 
as group A (n=114), and patients having 0.5 cm≤IPP＜1 cm were defined as group B 
(n=38). The others were defined as group C (n=27).
Results: A total of 51 patients complained of urgency in group A, 38 patients in group 
B, and 27 patients in group C. Likewise, 14 patients had a history of acute urinary re-
tention in group A, 8 patients in group B, and 16 patients in group C. IPP grade had 
a statistically significant relation with both OAB and a history of acute urinary 
retention.
Conclusions: The results of our study have shown that male OAB is correlated with IPP. 
However, larger scale studies are needed to confirm these results. 
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INTRODUCTION
Benign prostatic hyperplasia (BPH) is found in over half 
of 60-year-old men and in almost all of 80-year-old men, 
who develop bladder outlet obstruction and lower urinary 
tract symptoms [1]. Overactive bladder (OAB) is currently 
defined by the International Continence Society (ICS) as 
urgency, with or without urgency urinary incontinence, 
usually with frequency and nocturia, and in case of the 
presence of bladder outlet obstruction due to prostatic hy-
perplasia, 50% to 75% of cases are accompanied by OAB 
[2-4]. In addition, it has been reported that the higher the 
age and the more severe the lower tract obstruction, the 
higher the prevalence of OAB due to BPH [5,6]. Voiding 
symptoms are the most common in bladder outlet ob-
struction due to BPH; however, the most troublesome 
symptom for the patients is OAB caused by instability of 
the detrusor [7]. 
　Recently, studies on the correlation between the degree 
of intravesical prostatic protrusion (IPP) and bladder out-
let obstruction have been actively conducted, and correla-
tions of IPP with the storage symptom subscale of the 
International Prostate Symptom Score (IPSS) have been 
reported domestically [8]; however, the studies on the di-
rect correlations between the degree of IPP and OAB have 
not been sufficient. Therefore, this study analyzed the cor-
relations between IPP measured by transrectal ultra-
sonography (TRUS) and the symptoms of OAB. Korean J Urol 2010;51:843-846
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TABLE 1. Baseline demographics
Overall (n=179) Group A (n=114) Group B (n=38) Group C (n=27)
Age (yr) 70.1±7.5 69.4±6.4 71.8±9.3 70.4±8.7
Prostate  volume  (g)  53.9±33.0  41.2±18.3  57.0±31.6 102.8±36.9
Transitional zone volume (g)   32.0±24.4   22.9±13.2   32.7±22.1   68.9±29.1
IPSS 20.7±6.7 21.2±6.7 18.5±7.0 21.8±5.5
IPSS (QoL)    4.1±.1.1   4.1±1.1   4.0±1.4   4.4±0.5
IPSS: International Prostate Symptom Score, QoL: quality of life
TABLE 2. The correlation of PSA, prostate volume, prostatic transitional zone volme, VV, RV, Qmax, IPSS, and QoL with IPP grade
Group A (n=114),  Group B (n=38),  Group C (n=27), 
p-value
median (range)  median (range) median (range)
PSA (ng/ml)   3.1 (0.01-49.1)   3.0 (0.1-19.4)   7.9 (0.3-22.1) ＜0.01
Prostate volume (g)    41 (10.1-140.2)    57 (16 -152)  102 (25-297) ＜0.01
Transitional zone volume (g)    23 (5-89.6)    32 (8-85)    69 (8-157) ＜0.01
VV (ml)  165 (0-700)  171 (51-489)  149 (72-489) 0.69
RV (ml)    44 (0-680)    57 (0-313)    78 (0-277) 0.03
Qmax (ml/s)   9.2 (0-42.7)   9.6 (3.6-40.1)   8.8 (2.2-40.1) 0.85
IPSS  21.2 (4-35) 18.5 (5-32) 21.7 (11-33) 0.06
IPSS (QoL)   4.1 (0-6)   4.0 (1-6)   4.4 (3-6) 0.38
PSA: prostate-specific antigen, VV: voided volume, RV: residual volume, Qmax: maximum flow rate, IPSS: International Prostate 
Symptom Score, QoL: quality of life, IPP: intravesical prostatic protrusion
MATERIALS AND METHODS
We performed IPSS, TRUS (model Accuvix XQ, Medison), 
uroflowmetry (model Urodyn1000, Mediwatch), residual 
urine test by ultrasonography, and serum prostate-specific 
antigen (PSA) test for 208 patients over 40 years old who 
had visited the hospital from January 2007 to May 2010 ow-
ing to lower urinary tract symptoms. We also performed a 
retrospective study with 179 patients, excluding 23 pa-
tients who had diagnosed urinary tract infection, prostatic 
malignancy, ureteral or bladder stones, urethral stricture, 
or neurogenic bladder and 6 patients who had had a history 
of urogenital surgery. OAB was defined as patients who 
complained of symptoms with 2 points or more for the 4th 
questionnaire related to urgency on the IPSS, which was 
performed for all subjects. IPP was measured as the short-
est distance connecting the protruded end of the prostate 
into the bladder based on the bladder neck in the sagittal 
plane, which reflects the maximum longitudinal length of 
the prostate as suggested by Nose et al [9]. The patients 
were classified into 3 types according to grades by the de-
gree of protrusion: ＜5 mm, 5-10 mm, and ＞10 mm. Among 
179 patients, 115 patients were grade I (group A), 38 pa-
tients were grade II (group B), and 27 patients were grade 
III (group C) in IPP. IPP was measured by transrectal ultra-
sonography, and the volume of the prostate and the volume 
of the prostatic transitional zone were measured by trans-
rectal ultrasonography. The correlations of IPP grade with 
the volume of the prostate and the volume of the prostatic 
transitional zone and the correlations between IPP grade 
and OAB or acute urinary retention were analyzed. The 
statistical significance was tested for maximum flow rate 
and voided volume by uroflowmetry and residual urine vol-
ume by ultrasonography. The statistical analysis was con-
ducted by using SPSS ver. 12.0 (SPSS Inc., Chicago, IL, 
USA), and the one-way ANOVA test and multiple linear 
analysis were used to analyze the relationship of the 
factors. Statistical significance was defined as a p-value 
less than 0.05. 
RESULTS
The average age of the 179 patients was 70.1±7.5 years, and 
the mean IPSS, prostate volume, and prostate transitional 
zone volume were 20.7±6.7, 53.9±33.0, and 32.0±24.4, 
respectively. IPP was measured by using TRUS according 
to the method suggested by Nose et al [9]. The patients were 
classified according to IPP severity as group A (n=114) with 
IPP＜5 mm, group B (n=38) with IPP of 5-10 mm, and group 
C (n=27) with IPP ≥10 mm. The average age, mean IPSS, 
mean prostate volume, and mean transitional zone volume 
of group A were 69.4±6.4, 21.2±6.7, 41.2±18.3, and 22.9± 
13.2, respectively. In group B, the average age, mean IPSS, 
mean prostate volume, and mean transitional zone volume 
were 71.8±9.3, 18.5±7.0, 57.0±31.6, and 32.7±22.1, respec-
tively. In group C, the average age, mean IPSS, mean pro-
state volume, and mean transitional zone volume were 
70.4±8.7, 21.8±5.5, 102.8±36.9, and 68.9±29.1, respec-
tively (Table 1).
    In the one-way ANOVA, IPP grade showed a statistically 
significant (p＜0.05) effect on prostate volume, transi-
tional zone volume, PSA, and residual urine volume but not Korean J Urol 2010;51:843-846
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TABLE 4. Multiple linear regression analysis of the various 
factors affecting AUR
Variable Beta p-value
PSA (ng/ml) −0.1 0.099
Prostate volume (g) 0.2 0.367
Transitional zone volume (g) −0.2 0.459
VV (ml) −0.2 0.054
RV (ml) 1.7 0.093
Qmax (ml/s) 0.1 0.230
IPSS (symptom score) 0.2 0.057
IPSS (QoL) 0.0 0.763
IPP 0.4 ＜0.01
AUR: acute urinary retention, PSA: prostate-specific antigen, VV:
voided volume, RV: residual volume, Qmax: maximum flow rate,
IPSS: International Prostate Symptom Score, QoL: quality of life,
IPP: intravesical prostatic protrusion
TABLE 3. Multiple linear regression analysis of the various 
factors affecting OAB
Variable Beta p-value
PSA (ng/ml) −0.1 0.890
Prostate volume (g) −0.3 0.914
Transitional zone volume (g) 0.03 0.916
VV (ml) −0.2 0.859
RV (ml) 0.0 0.733
Qmax (ml/s) −0.1 0.542
IPSS 0.2 0.056
IPSS (QoL) 0.1 0.380
IPP 0.2 0.013
OAB: overactive bladder, PSA: prostate-specific antigen, VV: 
voided volume, RV: residual volume, Qmax: maximum flow rate,
IPSS: International Prostate Symptom Score, QoL: quality of life,
IPP: intravesical prostatic protrusion
on voided volume, maximum flow rate, or IPSS (Table 2). 
    Concerning the classifications by each IPP grade, 45% 
(51/114) of group A complained of urgency, 74% (28/38) of 
group B, and 70% (19/27) of group C. Likewise, 12% (14/114) 
of group A had a history of acute urinary retention, 21% 
(8/38) of group B, and 59% (16/27) of group C. By multiple 
linear regression analysis, IPP grade was statistically sig-
nificantly related to both OAB (p=0.01) (Table 3) and a his-
tory of acute urinary retention (p＜0.01) (Table 4). 
DISCUSSION
OAB symptoms are the most troublesome among the lower 
urinary tract symptoms, referring to cases showing ur-
gency as one of the storage symptoms [10]. Detrusor hyper-
activity is the most common cause of OAB symptoms and 
is often correlated with bladder outlet obstruction and BPH 
[11-14]. However, there is an argument that OAB symp-
toms and detrusor hyperactivity are not related to bladder 
outlet obstruction, but to aging [15]. This is supported by 
the EPIC study, which was a population-based cross-sec-
tional survey of adults 18 years of age or older in five coun-
tries (Canada, Germany, Italy, Sweden, and the UK). The 
results of that study showed no sexual difference in the 
prevalence of OAB but that the prevalence in both males 
and females increased with age. 
    Since Nose et al suggested the clinical implication of IPP 
[9], there have been many studies related to IPP and lower 
urinary tract symptoms. Kim et al reported the correla-
tions of prostate volume, serum PSA value, and IPSS ac-
cording to IPP severity measured by abdominal ultra-
sonography [16]. In addition, Keqin et al reported the corre-
lation of IPP with bladder outlet obstruction by classifying 
206 patients with IPP of ＞10 mm and ＜10 mm [17]. Doo 
and Uh reported the correlation of IPP with acute urinary 
retention in 157 patients [18], and Ku et al reported the cor-
relation of IPP with bladder outlet obstruction in 260 pa-
tients by measuring the prostatic urethral angle [19]. Lee 
et al analyzed the correlation of IPP with the storage symp-
tom score of the IPSS, referring to the fact that the storage 
symptom score was underestimated compared with the 
score for urination symptoms, and reported a high correla-
tion between IPP and the storage symptom score [8]. 
Moreover, our study reported the statistically significant 
relation between IPP and OAB, highlighting the correla-
tion of IPP with the questionnaires related to urgency 
among the questionnaires on storage scores in the IPSS. 
    Since the studies of IPP began, IPP was initially meas-
ured mainly by abdominal ultrasonography. However, this 
method can be used only in cases of bladder filling to about 
100 to 200 cc, reflecting the difficulty of IP measurement 
and the lower reliability in cases of an empty bladder. In 
the present study, we tried to enhance the accuracy of the 
results for IPP by using transrectal ultrasonography to fol-
low the recent trend and to minimize the tester’s error by 
performing ultrasonography by single tester. In the pres-
ent study, we reported not only the correlations of IPP with 
acute urinary retention, prostate volume, PSA, IPSS, and 
quality of life as shown in previous studies, but also the stat-
istically significant relation between IPP and OAB symp-
toms. 
　Further larger scale studies of the statistical signifi-
cance of IPP severity in relation to the symptom severity 
of OAB would to be helpful to generate more accurate 
results. Furthermore, the correlations between detrusor 
overactivity and IPP severity should be tested by use of ur-
odynamic study. 
CONCLUSIONS
The results of this study suggest that IPP, which reflects 
anatomical changes in the prostate, may be related to male 
OAB symptoms. We should actively consider this variable 
in the treatment of male OAB. 
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